While on faculty at a cancer pain meeting, Dr. Rosenberg encountered a new technology (Calmare nerve stimulation) claiming to address neuropathic pain using skin-based stimulation done in an office setting. Initially, he was very dubious, but one of the presentations in the meeting came from a senior researcher at the Mayo Clinic who demonstrated efficacy using the device with chemotherapy-induced neuropathy in a randomized, blinded study. This prompted him to try it himself and the short-term results were actually very remarkable.
Therefore, the Center decided to evaluate the technology for use in the office. We are currently treating a number of patients for the minimum 10 treatments and following the results. If they look encouraging, we will consider getting the device for use in the office. We will keep you posted as to the results.